News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Sanofi-Aventis (France) Addiction Drug Reverses Obesity in Rats
August 20, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Aug 20 (Reuters) - An epilepsy drug being tested for use in treating addiction can help obese rats shed weight, U.S. government researchers said on Wednesday.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
Sanofi (France)
MORE ON THIS TOPIC
Insights
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
January 15, 2026
·
2 min read
·
Jennifer Smith-Parker
Business
JPM26: Lilly Plots Path to Dominance as Obesity Market Enters a New Era
January 14, 2026
·
2 min read
·
Nick Paul Taylor
Podcast
Deals Roll at JPM26, Policy Front and Center, IPOs Are Back, FDA Stays Busy
January 14, 2026
·
2 min read
·
Heather McKenzie
Business
JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff
January 13, 2026
·
3 min read
·
Nick Paul Taylor
